Cargando…

Drug-Induced Intersticial Nephritis. Clinical Case

5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tekoriutė, Paulina, Matuliauskaitė, Monika, Jonaitis, Laimas Virginijus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Vilnius University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958646/
https://www.ncbi.nlm.nih.gov/pubmed/35474922
http://dx.doi.org/10.15388/Amed.2021.28.2.14
_version_ 1784676989318201344
author Tekoriutė, Paulina
Matuliauskaitė, Monika
Jonaitis, Laimas Virginijus
author_facet Tekoriutė, Paulina
Matuliauskaitė, Monika
Jonaitis, Laimas Virginijus
author_sort Tekoriutė, Paulina
collection PubMed
description 5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function.
format Online
Article
Text
id pubmed-8958646
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Vilnius University Press
record_format MEDLINE/PubMed
spelling pubmed-89586462022-04-25 Drug-Induced Intersticial Nephritis. Clinical Case Tekoriutė, Paulina Matuliauskaitė, Monika Jonaitis, Laimas Virginijus Acta Med Litu Case Studies 5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects. A rare side effect of this medicine is interstitial nephritis (IN). With discontinuation of the drug the renal function usually restores. However, if damage has not been detected for a long time, irreversible changes may occur. In this article, we present a clinical case of mesalamine induced IN. A 56-year-old man who has had ulcerative colitis for 20 years, was admitted due to mesalamine induced acute renal failure. A year before, the patient had been diagnosed with mesalamine-induced interstitial nephritis and the treatment with mesalamine was discontinued. The symptoms of ulcerative colitis worsened, and the patient independently decided to start taking mesalamine, which resulted in worsening of his health condition and impaired renal function. Mesalamine has been discontinued, additional treatment for acute kidney failure has been administered including hemodialysis. Renal function recovered and the patient was released for further treatment of ulcerative colitis and monitoring of renal function. Vilnius University Press 2021 2021-08-11 /pmc/articles/PMC8958646/ /pubmed/35474922 http://dx.doi.org/10.15388/Amed.2021.28.2.14 Text en Copyright © 2021 Paulina Tekoriutė, Monika Matuliauskaitė, Laimas Virginijus Jonaitis. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Studies
Tekoriutė, Paulina
Matuliauskaitė, Monika
Jonaitis, Laimas Virginijus
Drug-Induced Intersticial Nephritis. Clinical Case
title Drug-Induced Intersticial Nephritis. Clinical Case
title_full Drug-Induced Intersticial Nephritis. Clinical Case
title_fullStr Drug-Induced Intersticial Nephritis. Clinical Case
title_full_unstemmed Drug-Induced Intersticial Nephritis. Clinical Case
title_short Drug-Induced Intersticial Nephritis. Clinical Case
title_sort drug-induced intersticial nephritis. clinical case
topic Case Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958646/
https://www.ncbi.nlm.nih.gov/pubmed/35474922
http://dx.doi.org/10.15388/Amed.2021.28.2.14
work_keys_str_mv AT tekoriutepaulina druginducedintersticialnephritisclinicalcase
AT matuliauskaitemonika druginducedintersticialnephritisclinicalcase
AT jonaitislaimasvirginijus druginducedintersticialnephritisclinicalcase